Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-20-088369
Filing Date
2020-07-30
Accepted
2020-07-30 18:38:56
Documents
4
Effectiveness Date
2020-07-30

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2026011d1_s8.htm S-8 62528
2 EXHIBIT 5.1 tm2026011d1_ex5-1.htm EX-5.1 5674
3 EXHIBIT 23.1 tm2026011d1_ex23-1.htm EX-23.1 2418
4 EXHIBIT 99.1 tm2026011d1_ex99-1.htm EX-99.1 106661
  Complete submission text file 0001104659-20-088369.txt   178360
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-240197 | Film No.: 201061250
SIC: 2834 Pharmaceutical Preparations